These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15974994)

  • 21. [Drug therapy of heart failure].
    Follath F
    Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
    Vesely DL
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
    Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
    Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Medical treatment of heart failure: an analysis of actual treatment practices in outpatients in Switzerland. The Swiss "IMPROVEMENT of HF" Group].
    Muntwyler J; Follath F
    Schweiz Med Wochenschr; 2000 Aug; 130(34):1192-8. PubMed ID: 11013922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Medical treatment of cardiac insufficiency. Advances and controversies].
    Garnier LF
    Arch Mal Coeur Vaiss; 1988 Apr; 81(4):551-6. PubMed ID: 3136718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurohumoral blockade in CHF management.
    Willenbrock R; Philipp S; Mitrovic V; Dietz R
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1 Suppl 1():24-30. PubMed ID: 11967792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs, heart failure and quality of life: what are we achieving? What should we be trying to achieve?
    Doba N; Tomiyama H; Nakayama T
    Drugs Aging; 1999 Mar; 14(3):153-63. PubMed ID: 10220102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy for heart failure].
    Just H
    Ther Umsch; 2000 May; 57(5):313-20. PubMed ID: 10859991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newer concepts in the medical management of patients with congestive heart failure.
    Weintraub NL; Chaitman BR
    Clin Cardiol; 1993 May; 16(5):380-90. PubMed ID: 8504571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digitalis for treatment of congestive heart failure in patients in sinus rhythm.
    Hood WB; Dans AL; Guyatt GH; Jaeschke R; McMurray JJ
    Cochrane Database Syst Rev; 2004; (2):CD002901. PubMed ID: 15106182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AlbuBNP, a recombinant B-type natriuretic peptide and human serum albumin fusion hormone, as a long-term therapy of congestive heart failure.
    Wang W; Ou Y; Shi Y
    Pharm Res; 2004 Nov; 21(11):2105-11. PubMed ID: 15587934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BNP assays: predicting the future of CHF patients.
    Kinkade E; Frazier SK
    Nurse Pract; 2006 Dec; 31(12):36-41. PubMed ID: 17149134
    [No Abstract]   [Full Text] [Related]  

  • 33. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].
    Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
    Ter Arkh; 2006; 78(8):14-20. PubMed ID: 17078211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic modulation and optimization of energy consumption in heart failure.
    Ferrari R; Cicchitelli G; Merli E; Andreadou I; Guardigli G
    Med Clin North Am; 2003 Mar; 87(2):493-507, xii-xiii. PubMed ID: 12693736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug treatment of cardiac insufficiency with systolic dysfunction].
    Follath F
    Praxis (Bern 1994); 1997 Feb; 86(7):254-7. PubMed ID: 9139344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
    Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review: therapeutic concepts of congestive heart failure.
    Haustein KO
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):273-81. PubMed ID: 1974888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.
    Berger R; Huelsman M; Strecker K; Bojic A; Moser P; Stanek B; Pacher R
    Circulation; 2002 May; 105(20):2392-7. PubMed ID: 12021226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of B-type natriuretic peptide in heart failure.
    Nappi JM
    Crit Care Nurs Clin North Am; 2003 Dec; 15(4):461-5. PubMed ID: 14717391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.